Implementing a Childhood Cancer Outcomes Surveillance System Within a Population-Based Cancer Registry

Journal of Global Oncology
Oscar RamirezVIGICANCER working group

Abstract

Approximately 80% of cases of childhood cancer occur in low- and middle-income countries and are associated with high mortality rates. Assessing outcomes is essential for designing effective strategies to improve outcomes equally worldwide. We implemented a real-time surveillance system, VIGICANCER, embedded in a population-based cancer registry (PBCR) to assess childhood cancer outcomes. VIGICANCER was established in 2009 as an integral part of Cali's PBCR to collect real-time data on outcomes of patients (age < 19 years) with a new diagnosis of cancer treated in pediatric oncology units in Cali, Colombia. Baseline and follow-up data (death, relapse, treatment abandonment, second neoplasms) were collected from medical records, hospital discharge logs, pathology reports, death certificates, and the National Public Health Insurance database. A quality assurance process was implemented for the system. From 2009 to 2013, data from 1,242 patients were included in VIGICANCER: 32% of patients were younger than 5 years, 55% were male, and 15% were Afro-descendants. International Classification of Childhood Cancer group I diagnoses predominated in all age groups except children younger than 1 year old, in whom CNS tumors predominated. ...Continue Reading

References

Mar 23, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M G ValsecchiUNKNOWN Monza's International School of Paediatric Hematology-Oncology
Feb 16, 2005·Cancer·Eva Steliarova-FoucherPeter Kaatsch
Jan 26, 2007·Pediatric Blood & Cancer·Ramandeep Singh AroraBarry Pizer
Sep 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stewart J Kellie, Scott C Howard
Mar 10, 2009·The Lancet Oncology·Adrian Burton
May 6, 2009·Health Affairs·Ursula Giedion, Manuela Villar Uribe
Jan 9, 2013·Current Opinion in Pediatrics·Carlos Rodriguez-GalindoLindsay Frazier
Feb 26, 2013·The Lancet Oncology·Ian MagrathScott C Howard
Jul 26, 2013·European Journal of Preventive Cardiology·Fábio AraújoNuno Lunet
Dec 10, 2013·The Lancet Oncology·Gemma GattaUNKNOWN EUROCARE Working Group
Feb 4, 2014·CA: a Cancer Journal for Clinicians·Elizabeth WardAhmedin Jemal
May 24, 2014·Cancer·Malcolm A SmithNita L Seibel
May 23, 2015·Cancer Epidemiology·Florencia MorenoUNKNOWN ROHA network

❮ Previous
Next ❯

Citations

May 21, 2020·Journal of the National Cancer Institute·Marion PiñerosEva Steliarova-Foucher
Sep 24, 2020·Pharmacology Research & Perspectives·Juan-Sebastian Franco, David Vizcaya

❮ Previous
Next ❯

Software Mentioned

STATA
VIGICANCER

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.